Sakura Finetek Japan will continue to support customers in histopathology during the state of emergency (～May 31st, 2020)
As the spread of COVID-19 continues, we would like to express our heartfelt gratitude to the medical community and non-medical support staff who work tirelessly to care for patients, to the employees of key infrastructure industries who risk their well-being to help us maintain our quality of life and to the families of these courageous individuals. We pray that this challenging situation will improve soon and we pledge to do our part as individuals an
d as an organization to help curb the spread of COVID-19.
Although the increase in the number of new cases of COVID-19 has been steadily decreasing, the Japanese government has designated 13 prefectures, including Tokyo, as ” special alert prefectures ” and is focusing its efforts on infection control.
Nagano Prefecture, where our manufacturing plant is located, is not included in this declaration, and we will take the necessary measures to minimize its impact.
Additionally, Sakura Finetek Japan is announcing the following policies and measures until May 31, 2020, in order to help curb the spread of the disease and ensure that we can continue to serve our customers.
Infection Control and Business Continuity Policy
1. Infection control – we aim to protect the lives of our employees and their families and prevent the spread of COVID-19.
2. Business continuity – we will continue to serve and support the needs of histopathology labs, in accordance with our mission of “Advancing Cancer Diagnostics”.
Measures to Combat the Spread of COVID-19
1. We appreciate your understanding regarding the canceling of face-to-face visits or meetings. We respect your decision and the decision of our employees to cancel visits or meetings due to infection concerns.
2. All Sakura Finetek Japan employees are working from home and no domestic/overseas business travel is permitted. However, Sakura Finetek Japan takes its role in ensuring that your healthcare system remains operational very seriously and therefore urgent corrective maintenance will be executed. This rule is in force until further notice.
Uninterrupted supply of histopathology equipment, consumables and services to you is our priority.
There is currently no serious delay in product delivery, but should this situation change, we will inform you immediately.
We appreciate your understanding toward the current situation.